CD Protein Inhibitors 

  Products    Products    Diseases    News 

«12...1415161718192021222324...2728»
Download options
                                                                                                      
 Phase 
N/A
1
2
3
4
 Trials
 02815628431124140516861967224825292810
            
            
             
CBM-C20.1 / AbelZeta Pharma           
          
            
             
CC-96191 / BMS           
          
            
             
CCW702 / AbbVie           
          
            
             
CCX559 / Amgen           
          
            
             
CD123-CAR T cell therapy / St. Jude Children's Research Hospital           
          
            
             
CD123R(EQ)28zeta/EGFRt+ T cells / National Cancer Institute           
          
            
             
CD147-CAR T cells / Peking University People's Hospital           
          
            
             
CD19 CAR-T cells / Z-park Sanly Regenerative Medicine Research Centre           
          
            
             
CD19 UCAR-T / Suzhou Maximum Bio-tech           
          
            
             
CD19 UCART cells / China Biotech Services           
          
            
             
CD19 targeted CAR-T / Southwest Hospital           
          
            
             
CD19-BCMA CAR-T cell therapy / Shanghai Ultra-T Immune Therap           
          
            
             
CD19-BCMA UCAR-T / Suzhou Maximum Bio-tech           
          
            
             
CD19-CAR-DNT / Ruichuang Bio, Zhejiang Ruijiamei Biotech           
          
            
             
CD19-CAR-T2 cells / Southern Medical University           
          
            
             
CD19-CAR.CD45RA- negative T-cells / St. Jude Children's Research Hospital           
          
            
             
CD19-CAR_Lenti T cells / Bambino Gesu Hospital           
          
            
             
CD19-CD34 CAR transduced T cells / Loyola University           
          
            
             
CD19-CD34t metabolically programmed CAR transduced T-cells / Medical University of South Carolina           
          
            
             
CD19-PD1-CART cell / Chinese PLA General Hospital           
          
            
             
CD19/CD20 CAR T-cells / PersonGen Biomedicine           
          
            
             
CD19/CD20/CD22 CAR-T / Xuzhou Medical University           
          
            
             
CD19/CD22 dual target CAR T / Beijing Boren Hospital           
          
            
             
CD19/CD22 dual-target CAR-T / Shenzhen University General Hospital           
          
            
             
CD20-CD19 cCAR T cells / iCell Gene Therap           
          
            
             
CD22-targeted CAR-T cell therapy / PersonGen Biomedicine           
          
            
             
CD22/CD19 CAR T / The First Affiliated Hospital of Soochow University           
          
            
             
CD30 biAb-AATC / Medical College of Wisconsin, Tundra Targeted Therap           
          
            
             
CD33 CAR T cells / Beijing Boren Hospital           
          
            
             
CD33 CAR-T / Alaunos Therap, Precigen           
          
            
             
CD33 UCAR-T / Suzhou Maximum Bio-tech           
          
            
             
CD33CART / Center for International Blood and Marrow Transplant Research           
          
            
             
CD38-SADA / Y-mAbs Therap           
          
            
             
CD40.HIVRI.Env / ANRS           
          
            
             
CD5 CAR T (CT125B) / Beijing Boren Hospital           
          
            
             
CD7-UCAR-γδT cells / PersonGen Biomedicine           
          
            
             
CD79b CAR-T cell therapy / Shanghai Yake Biotech           
          
            
             
CDX-527 / Celldex           
          
            
             
CDX-585 / Celldex           
          
            
             
CHECKvacc (CF33-hNIS-antiPDL1) / Imugene           
          
            
             
CHS-1000 / Coherus Biosci           
          
            
             
CID-103 / CASI, Precision Autoimmune Therap           
          
            
             
CLDN18.2/CD19 targeted CAR-T / Innovative Cellular Therapeutics           
          
            
             
CLL-1, CD33 and/or CD123-specific CAR gene-engineered T cells / SZGIMI           
          
            
             
CLL1+CD33 CAR-T / Hedy Group, Zhejiang University           
          
            
             
CLL1-CD33 cCART cell therapy / iCell Gene Therap           
          
            
             
CLL1/CD33/CD123 CAR T cells / Hedy Group           
          
            
             
CLN-049 / Cullinan Therap           
          
            
             
CM336 / Keymed Biosciences           
          
            
             
CM350 / Keymed Biosciences           
          
            
            


«12...1415161718192021222324...2728»